SYNERGISTIC INCREASES IN RAT HEPATIC CYTOCHROME P450S BY ETHANOL AND ISOPENTANOL

被引:1
|
作者
LOUIS, CA
WOOD, SG
KOSTRUBSKY, V
SINCLAIR, PR
SINCLAIR, JF
机构
[1] VET ADM MED CTR,WHITE RIVER JCT,VT 05009
[2] DARTMOUTH COLL SCH MED,DEPT PHARMACOL & TOXICOL,HANOVER,NH
[3] DARTMOUTH COLL SCH MED,DEPT BIOCHEM,HANOVER,NH
来源
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 1994年 / 269卷 / 02期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this study was to determine if isopentanol alone or in combination with ethanol increased CYP2B1/2, CYP2E or CYP3A in the livers of rats. Increasing doses of isopentanol (0.5, 1, 2 or 3%) were administered in combination with 5.6% ethanol in the Lieber-DeCarli liquid diet for 7 days. Doses of 0.5 or 3% isopentanol were also administered alone. Isopentanol alone caused small increases in CYP2B1/2 and CYP3A. However, when isopentanol (2 or 3%) was combined with ethanol a synergistic increase in P450281/2 was observed. The combined alcohol treatment also resulted in a greater increase in immunoreactive CYP3A than either alcohol alone. Ethanol alone increased CYP2E 5-fold. Inclusion of isopentanol with ethanol resulted in either small or no additional increases in CYP2E. These results confirm our previous findings in cultured hepatocytes that when isopentanol is combined with ethanol, there is a synergistic increase in CYP2B1/2. Increases in CYP2B1/2, CYP2E and CYP3A protein moieties by ethanol, and by ethanol in combination With isopentanol, were associated with increases in their mRNAs. Blood isopentanol levels were 10-fold greater in rats administered 3% isopentanol in combination with ethanol compared to rats administered 3% isopentanol alone. From these results we suggest that isopentanol, a higher chain alcohol in alcoholic beverages, can contribute to increases in hepatic cytochrome P450 observed following consumption of alcoholic beverages.
引用
收藏
页码:838 / 845
页数:8
相关论文
共 50 条
  • [21] Hepatic cytochrome P450S in rats deficient in folate and niacin.
    Zhang, J
    Henning, SM
    Choi, J
    Swendseid, ME
    Go, VLW
    FASEB JOURNAL, 1996, 10 (03): : 2857 - 2857
  • [22] Autoactivation and activation of the cytochrome P450s
    Ekins, S
    Ring, BJ
    Binkley, SN
    Hall, SD
    Wrighton, SA
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1998, 36 (12) : 642 - 651
  • [23] Cytochrome P450s in flavonoid metabolism
    Ayabe S.-I.
    Akashi T.
    Phytochemistry Reviews, 2006, 5 (2-3) : 271 - 282
  • [24] The Medicinal Chemistry of the Cytochrome P450s
    Sykes, Matthew
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2013, 13 (18) : 2217 - 2217
  • [25] Engineering cytochrome P450s for bioremediation
    Kellner, DG
    Maves, SA
    Sligar, SG
    CURRENT OPINION IN BIOTECHNOLOGY, 1997, 8 (03) : 274 - 278
  • [26] Novel extrahepatic cytochrome P450s
    Karlgren, M
    Oscarson, M
    Ingelman-Sundberg, M
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 197 (03) : 142 - 142
  • [27] The ins and outs of cytochrome P450s
    Cojocaru, Vlad
    Winn, Peter J.
    Wade, Rebecca C.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2007, 1770 (03): : 390 - 401
  • [28] Functions of minor cytochrome P450s
    Ingelman-Sundberg, Magnus
    DRUG METABOLISM REVIEWS, 2006, 38 : 4 - 5
  • [29] SUBSTRATE RECOGNITION BY CYTOCHROME P450S
    Scott, Emily E.
    Bart, Aaron G.
    DRUG METABOLISM AND PHARMACOKINETICS, 2020, 35 (01) : S11 - S12
  • [30] Interactions of cytochrome P450s with their ligands
    Conner, Kip P.
    Woods, Caleb M.
    Atkins, William M.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2011, 507 (01) : 56 - 65